No biomarker	Prostate Cancer	No biomarker	Prostate Cancer	abiraterone acetate Sensitive: A1 - Approval abiraterone acetate Sensitive : A1	abiraterone acetate Sensitive: A1 - Approval abiraterone acetate Sensitive : A1
BRCA1 mutation	Prostate Cancer	BRCA1 mutation	Prostate Cancer	abiraterone/niraparib Sensitive: A1 - Approval abiraterone / niraparib Sensitive : A1	abiraterone/niraparib Sensitive: A1 - Approval abiraterone / niraparib Sensitive : A1
BRCA2 mutation	Prostate Cancer	BRCA2 mutation	Prostate Cancer	abiraterone/niraparib Sensitive: A1 - Approval abiraterone / niraparib Sensitive : A1	abiraterone/niraparib Sensitive: A1 - Approval abiraterone / niraparib Sensitive : A1
AR splice variant 7	Prostate Cancer	AR splice variant 7	Prostate Cancer	abiraterone acetate Resistant: A2 - Guideline abiraterone acetate Resistant : A2	abiraterone acetate Resistant: A2 - Guideline abiraterone acetate Resistant : A2
No biomarker	Prostate Cancer	No biomarker	Prostate Cancer	abiraterone acetate + degarelix Sensitive: A2 - Guideline abiraterone acetate + degarelix Sensitive : A2	abiraterone acetate + degarelix Sensitive: A2 - Guideline abiraterone acetate + degarelix Sensitive : A2
No biomarker	Prostate Cancer	No biomarker	Prostate Cancer	abiraterone acetate + triptorelin Sensitive: A2 - Guideline abiraterone acetate + triptorelin Sensitive : A2	abiraterone acetate + triptorelin Sensitive: A2 - Guideline abiraterone acetate + triptorelin Sensitive : A2
No biomarker	Prostate Cancer	No biomarker	Prostate Cancer	abiraterone acetate + leuprolide acetate Sensitive: A2 - Guideline abiraterone acetate + leuprolide acetate Sensitive : A2	abiraterone acetate + leuprolide acetate Sensitive: A2 - Guideline abiraterone acetate + leuprolide acetate Sensitive : A2
No biomarker	Prostate Cancer	No biomarker	Prostate Cancer	abiraterone acetate + histrelin acetate Sensitive: A2 - Guideline abiraterone acetate + histrelin acetate Sensitive : A2	abiraterone acetate + histrelin acetate Sensitive: A2 - Guideline abiraterone acetate + histrelin acetate Sensitive : A2
No biomarker	Prostate Cancer	No biomarker	Prostate Cancer	abiraterone acetate + goserelin acetate Sensitive: A2 - Guideline abiraterone acetate + goserelin acetate Sensitive : A2	abiraterone acetate + goserelin acetate Sensitive: A2 - Guideline abiraterone acetate + goserelin acetate Sensitive : A2
No biomarker	Prostate Cancer	No biomarker	Prostate Cancer	abiraterone acetate + dexamethasone Sensitive: A2 - Guideline abiraterone acetate + dexamethasone Sensitive : A2	abiraterone acetate + dexamethasone Sensitive: A2 - Guideline abiraterone acetate + dexamethasone Sensitive : A2
No biomarker	Prostate Cancer	No biomarker	Prostate Cancer	CYP17A1 inhibitor Sensitive: B - Late Trials CYP17A1 inhibitor Sensitive : B	CYP17A1 inhibitor Sensitive: B - Late Trials CYP17A1 inhibitor Sensitive : B
AR amplification	Prostate Cancer	AR amplification	Prostate Cancer	abiraterone acetate Resistant: B - Late Trials abiraterone acetate Resistant : B	abiraterone acetate Resistant: B - Late Trials abiraterone acetate Resistant : B

CYP17A1 inhibitor

CYP17A1 inhibitor

Associations(63)

Associations
(63)